What is the current Orbital Atherectomy Device market size?

The Orbital Atherectomy Device market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Orbital Atherectomy Device market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Orbital Atherectomy Device market?

Key drivers include rising incidence of cardiovascular diseases and advancements in medical technology.

What are the major challenges facing the Orbital Atherectomy Device market?

Challenges include high costs, limited awareness, and stringent regulatory requirements.

Which regions are the leaders in the Orbital Atherectomy Device market?

North America and Europe are the leading regions, due to well-established healthcare infrastructure.

Who are the top companies in the Orbital Atherectomy Device market?

Top companies include Medtronic, Boston Scientific, and Cardinal Health, driving innovation and growth.

What are the future opportunities in the Orbital Atherectomy Device market?

Future opportunities include emerging markets, technological advancements, and increasing adoption of minimally invasive procedures.

How will technology impact the Orbital Atherectomy Device market?

Advances in technology will improve device efficacy, enhance patient outcomes, and drive the future outlook of the market.

What is the current regulatory landscape for the Orbital Atherectomy Device market?

The regulatory landscape is stringent, with FDA and CE mark approvals required for market entry and expansion.

What does the future outlook of the Orbital Atherectomy Device market look like?

The future outlook is promising, with growing demand and increasing adoption of Orbital Atherectomy Devices expected to drive market growth.

How Big Is the Orbital Atherectomy Device Market? Size, Share & Forecast 2033

Orbital Atherectomy Device by Type (Peripheral Vascular, Cardiovascular, Neurovascular, World Orbital Atherectomy Device Production), by Application (Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes, World Orbital Atherectomy Device Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Orbital Atherectomy Device Market Overview

The Orbital Atherectomy Device market refers to the industry that develops and manufactures devices used to treat peripheral artery disease (PAD) and other vascular conditions. As a crucial segment of the medical device industry, the Orbital Atherectomy Device market size is expected to experience significant growth, driven by an increasing demand for minimally invasive procedures and advancements in technology. The growth outlook for this market is promising, with a projected market forecast that indicates a compound annual growth rate (CAGR) of around 7-8% from 2026 to 2033, resulting in substantial industry expansion. The scope of this market encompasses various types of orbital atherectomy devices, including diamondback 360 and predator 360, which are used in hospitals, clinics, and other healthcare facilities.

Loading chart…

The current Orbital Atherectomy Device market size is estimated to be around $245 million, with the largest region being North America, driven by the high prevalence of PAD and the presence of major market players. The fastest-growing region is expected to be the Asia-Pacific, driven by increasing healthcare expenditure and improving healthcare infrastructure. Key forces shaping the industry include technology shifts, such as the development of more efficient and minimally invasive devices, regulations, such as the need for FDA clearance, and competitive intensity, with major players competing for market share. Overall, the Orbital Atherectomy Device market is poised for significant growth, driven by an increasing demand for effective and minimally invasive treatments for vascular conditions.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic (Ireland); Philips (Netherlands); Boston Scientific (US); Cardiovascular Systems (US); Straub Medical (Switzerland); BIOTRONIK (Netherlands); C.R. Bard (US); Avinger (US)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Orbital Atherectomy Device market is poised for significant growth, driven by factors such as increasing demand for minimally invasive procedures and advancements in technology. The Orbital Atherectomy Device market size is expected to expand at a considerable growth forecast, driven by the rising prevalence of peripheral artery disease and the growing need for effective treatment options.

Growth Drivers2 items

Increasing adoption of orbital atherectomy devices in hospitals and ambulatory surgical centers, driven by their ability to effectively treat complex calcified lesions

Advances in device technology, including the development of more efficient and user-friendly orbital atherectomy systems, which are expected to drive the growth of the Orbital Atherectomy Device market

Restraints2 items

High cost of orbital atherectomy devices, which can be a significant barrier to adoption, particularly in developing countries with limited healthcare budgets

Stringent regulatory requirements, which can slow down the approval and commercialization of new orbital atherectomy devices, thereby limiting the growth of the Orbital Atherectomy Device market size

Opportunities2 items

Growing demand for minimally invasive procedures in emerging markets, which is expected to drive the adoption of orbital atherectomy devices and contribute to the growth forecast of the Orbital Atherectomy Device market

Increasing focus on clinical research and trials, which can provide valuable insights into the safety and efficacy of orbital atherectomy devices and drive innovation in the Orbital Atherectomy Device market

Challenges2 items

Intense competition in the Orbital Atherectomy Device market, which can make it challenging for manufacturers to differentiate their products and maintain market share

Need for specialized training and education for healthcare professionals to effectively use orbital atherectomy devices, which can be a significant challenge, particularly in resource-constrained settings

Market Segmentation

Loading chart…

The Orbital Atherectomy Device market can be segmented based on Type, which includes different types of devices such as orbital atherectomy systems and catheters. This segmentation contributes to the overall market size by providing a detailed understanding of the various devices used in orbital atherectomy procedures. The Type segment plays a crucial role in the Orbital Atherectomy Device segmentation as it helps to identify the market share of each device type, enabling manufacturers to develop targeted strategies for product development and marketing.

The Orbital Atherectomy Device market can also be segmented based on Application, which includes various applications such as peripheral artery disease treatment and coronary artery disease treatment. This segmentation is crucial in understanding the market size and growth prospects of the Orbital Atherectomy Device market. The Application segment is essential in market taxonomy as it helps to identify the most significant applications of orbital atherectomy devices, enabling manufacturers to focus on developing devices that cater to the needs of specific applications.

Orbital Atherectomy Device Segmentation Breakdown10 items

Type

Peripheral Vascular

Cardiovascular

Neurovascular

World Orbital Atherectomy Device Production

Application

Hospitals & Surgical Centers

Ambulatory Care Centers

Research Laboratories & Academic Institutes

World Orbital Atherectomy Device Production

Regional Insights

Loading chart…

The Orbital Atherectomy Device market growth is expected to vary across regions, with North America being the largest region, holding a significant share of the market. The regional forecast indicates that North America will dominate the market due to high adoption rates of orbital atherectomy devices, favorable policies, and substantial investments in healthcare infrastructure.

The fastest-growing region is expected to be Asia Pacific, driven by increasing demographics, improving infrastructure, and growing ecosystem maturity. Key drivers for this region include rising demand for minimally invasive procedures, expanding healthcare coverage, and growing awareness of cardiovascular diseases.

In Europe, key drivers include established healthcare systems, high disposable incomes, and stringent regulatory frameworks. Latin America and Middle East & Africa are expected to witness moderate growth, driven by increasing investments in healthcare, growing demand for cardiovascular treatments, and improving economic conditions.

Competitive Landscape

The Orbital Atherectomy Device market exhibits a moderately consolidated structure, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Orbital Atherectomy Device competitive landscape is characterized by high competition, with companies focusing on differentiation through technology, service models, and channel strength. Global players such as Medtronic and Philips have a significant presence, while local companies focus on regional expansion and customization.

Companies in the Orbital Atherectomy Device market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, and R&D. Common challenges faced by these companies include margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on innovation, localization, and cost advantages. The following companies have adopted distinct strategies:

Medtronic (Ireland) - regional expansion

Philips (Netherlands) - premium pricing

Boston Scientific (US) - innovation pipeline

Cardiovascular Systems (US) - local manufacturing

Straub Medical (Switzerland) - OEM tie-ups

BIOTRONIK (Netherlands) - vertical integration

Key Orbital Atherectomy Device Companies8 items

Medtronic (Ireland)

Philips (Netherlands)

Boston Scientific (US)

Cardiovascular Systems (US)

Straub Medical (Switzerland)

BIOTRONIK (Netherlands)

C.R. Bard (US)

Avinger (US)

Market Ecosystem

The Orbital Atherectomy Device ecosystem spans across upstream, midstream, and downstream segments, involving various participants who contribute to the creation and capture of value. Upstream participants, such as technology providers and suppliers, provide critical components and expertise, while midstream integrators and manufacturers assemble and refine the devices. Downstream channels and end users ultimately receive and utilize the finished products, influencing the ecosystem's overall direction through their adoption and feedback.

Raw material/component suppliers — provide critical device components

OEMs / manufacturers — design and assemble Orbital Atherectomy Devices

System integrators / EPCs — integrate devices into larger medical systems

Distributors / channel partners — supply devices to healthcare providers

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize Orbital Atherectomy Devices in medical procedures

Regulators/standards bodies — establish and enforce device safety and efficacy standards

Within the Orbital Atherectomy Device ecosystem, control points are primarily held by regulators and end users, who influence adoption through their approval and utilization of devices. Dependency risks, such as input constraints and standards compliance, can impact the ecosystem's functioning. Additionally, switching costs and interoperability requirements may affect partnerships and collaborations among participants. As the ecosystem differs by region, due to varying regulatory frameworks and market conditions, a thorough value chain analysis is necessary to understand the complex interactions and relationships between participants.

Recent Industry Insights

The Orbital Atherectomy Device industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have led to the expansion of product portfolios and enhanced market reach. Notable mergers and acquisitions have also contributed to the consolidation of the market, enabling companies to leverage each other's strengths and technologies.

Furthermore, the introduction of advanced product launches and technologies has improved the efficacy and safety of orbital atherectomy procedures. Regulatory changes have also played a crucial role in shaping the industry, with updated guidelines and approvals influencing the adoption of these devices. As a result, the Orbital Atherectomy Device industry is poised for growth, driven by shifting consumer and enterprise trends, as well as significant funding rounds and expansions.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Orbital Atherectomy Device market outlook. The market exhibits moderate attractiveness due to increasing demand for minimally invasive procedures and a growing patient population with peripheral artery disease. Competitive intensity is high, with key players investing heavily in research and development to enhance their product offerings. The long-term outlook appears promising, driven by advancements in technology and an expanding innovation landscape. However, the demand–supply balance may be affected by regulatory challenges and reimbursement issues. Key risk factors include intense competition and potential supply chain disruptions. Overall, the Orbital Atherectomy Device market is poised for growth, with opportunities for manufacturers to capitalize on emerging trends and technologies.

12 items

1. Executive Summary

2. Orbital Atherectomy Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Orbital Atherectomy Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Orbital Atherectomy Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Orbital Atherectomy Device Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Orbital Atherectomy Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Orbital Atherectomy Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Orbital Atherectomy Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Orbital Atherectomy Device Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Orbital Atherectomy Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Orbital Atherectomy Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Orbital Atherectomy Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Orbital Atherectomy Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Orbital Atherectomy Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Orbital Atherectomy Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Orbital Atherectomy Device Market Competition by Key Manufacturers

9.1. Global Orbital Atherectomy Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Orbital Atherectomy Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic (Ireland)

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Philips (Netherlands)

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Boston Scientific (US)

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Cardiovascular Systems (US)

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Straub Medical (Switzerland)

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. BIOTRONIK (Netherlands)

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. C.R. Bard (US)

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Avinger (US)

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Orbital Atherectomy Device Market

Figure 4: Global Orbital Atherectomy Device Market: Drivers

Figure 5: Global Orbital Atherectomy Device Market: Challenges

Figure 6: Global Orbital Atherectomy Device Market: Trends

Figure 7: Global Orbital Atherectomy Device Market: Opportunity

Figure 8: Global Orbital Atherectomy Device Market: Restraint

Figure 9: Global Orbital Atherectomy Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Orbital Atherectomy Device Market Value (USD Million) By Region

Figure 19: Global Orbital Atherectomy Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Orbital Atherectomy Device Market Value (USD Million) By Region

Figure 27: Global Orbital Atherectomy Device Market Share (%) By: Regions (2032)

Figure 28: Global Orbital Atherectomy Device Market Volume (K) By Region

Figure 29: Global Orbital Atherectomy Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Orbital Atherectomy Device Market Value (USD Million) By Region

Figure 37: Global Orbital Atherectomy Device Market Share (%) By: Regions (2032)

Figure 38: Global Orbital Atherectomy Device Market Volume (K) By Region

Figure 39: Global Orbital Atherectomy Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Orbital Atherectomy Device Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Orbital Atherectomy Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Orbital Atherectomy Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Orbital Atherectomy Device Market Value (USD Million) By Region

Table 14: Global Orbital Atherectomy Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Orbital Atherectomy Device Market Volume (K) By Region

Table 31: Global Orbital Atherectomy Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Orbital Atherectomy Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Orbital Atherectomy Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Orbital Atherectomy Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic (Ireland) Basic Information And Sales Area

Table 52: Medtronic (Ireland). Products Portfolio

Table 53: Philips (Netherlands) Basic Information And Sales Area

Table 54: Philips (Netherlands). Products Portfolio

Table 55: Boston Scientific (US) Basic Information And Sales Area

Table 56: Boston Scientific (US). Products Portfolio

Table 57: Cardiovascular Systems (US) Basic Information And Sales Area

Table 58: Cardiovascular Systems (US). Products Portfolio

Table 59: Straub Medical (Switzerland) Basic Information And Sales Area

Table 60: Straub Medical (Switzerland). Products Portfolio

Table 61: BIOTRONIK (Netherlands) Basic Information And Sales Area

Table 62: BIOTRONIK (Netherlands). Products Portfolio

Table 63: C.R. Bard (US) Basic Information And Sales Area

Table 64: C.R. Bard (US). Products Portfolio

Table 65: Avinger (US) Basic Information And Sales Area

Table 66: Avinger (US). Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Type

Table 68: Global Market Share (%) By Type (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Type

Table 72: Global Market Share (%) By Type (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Orbital Atherectomy Device Market Value (USD Million) By Region

Table 76: Global Orbital Atherectomy Device Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Type

Table 79: North America Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Type

Table 82: Europe Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Type

Table 88: South America Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 92: Global Orbital Atherectomy Device Market Volume (K) By Region

Table 93: Global Orbital Atherectomy Device Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Type

Table 96: North America Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Type

Table 99: Europe Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Type

Table 105: South America Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Orbital Atherectomy Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic (Ireland); Philips (Netherlands); Boston Scientific (US); Cardiovascular Systems (US); Straub Medical (Switzerland); BIOTRONIK (Netherlands); C.R. Bard (US); Avinger (US)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing adoption of orbital atherectomy devices in hospitals and ambulatory surgical centers, driven by their ability to effectively treat complex calcified lesions

Restraints2 items

High cost of orbital atherectomy devices, which can be a significant barrier to adoption, particularly in developing countries with limited healthcare budgets

Opportunities2 items

Challenges2 items

Intense competition in the Orbital Atherectomy Device market, which can make it challenging for manufacturers to differentiate their products and maintain market share

Market Segmentation

Loading chart…

Orbital Atherectomy Device Segmentation Breakdown10 items

Type

Peripheral Vascular

Cardiovascular

Neurovascular

World Orbital Atherectomy Device Production

Application

Hospitals & Surgical Centers

Ambulatory Care Centers

Research Laboratories & Academic Institutes

World Orbital Atherectomy Device Production

Regional Insights

Loading chart…

Competitive Landscape

Medtronic (Ireland) - regional expansion

Philips (Netherlands) - premium pricing

Boston Scientific (US) - innovation pipeline

Cardiovascular Systems (US) - local manufacturing

Straub Medical (Switzerland) - OEM tie-ups

BIOTRONIK (Netherlands) - vertical integration

Key Orbital Atherectomy Device Companies8 items

Medtronic (Ireland)

Philips (Netherlands)

Boston Scientific (US)

Cardiovascular Systems (US)

Straub Medical (Switzerland)

BIOTRONIK (Netherlands)

C.R. Bard (US)

Avinger (US)

Market Ecosystem

Raw material/component suppliers — provide critical device components

OEMs / manufacturers — design and assemble Orbital Atherectomy Devices

System integrators / EPCs — integrate devices into larger medical systems

Distributors / channel partners — supply devices to healthcare providers

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize Orbital Atherectomy Devices in medical procedures

Regulators/standards bodies — establish and enforce device safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents